Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

ELCC 2026: Preoperative Nucleosome Liquid Biopsy for Prognostic Stratification in Lung Cancer With Treatment Correlation

Wednesday, March 25, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster presented at ELCC 2026 discusses the use of preoperative nucleosome liquid biopsy for prognostic stratification in lung cancer. The research highlights the correlation between the biopsy results and treatment outcomes, showcasing the potential of this technology in enhancing patient management. The findings contribute to the growing body of evidence supporting liquid biopsy applications in oncology.
Price reaction · baseline $4.022 (2026-03-24 close) · hit pre-market · 6 other VNRX headline(s) in the window, move may be shared
day 0 close
-4.9%
day 1
-4%
day 3
-5.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a significant conference (ELCC 2026)
  • Focus on innovative liquid biopsy technology for lung cancer
  • Potential for improved prognostic stratification in treatment

Full Press Release Details

Poster titled: Preoperative Nucleosome Liquid Biopsy for Prognostic Stratification in Lung Cancer With Treatment Correlation
Pei-Hsing Chen, Chia-Wei Weng, Tai-Horng Young, Tzu-Pin Lu, D. Pamart, A. Kotronoulas, M. Herzog, J. Micallef, Hsao-Hsun Hsu, Jin-Shing Chen
Presented at ELCC 2026

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was presented at ELCC 2026?

A poster on preoperative nucleosome liquid biopsy for lung cancer prognostic stratification.

What is the focus of the nucleosome liquid biopsy?

It aims to improve prognostic stratification and treatment correlation in lung cancer.

Who were the authors of the study?

The study was authored by Pei-Hsing Chen and colleagues.

What does the Nu.Q® Cancer Test relate to?

It is related to the prognostic value in cancer assessment.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare lung cancer liquid biopsy prognostic stratification ELCC 2026
Last updated: Mar 25, 2026

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk